title: Letter to the editor about the reviewer comment to our article entitled 'Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial'.
authors.forename: Francesca
authors.initials: F
authors.lastname: Mallamaci
authors.forename: Giovanni
authors.initials: G
authors.lastname: Tripepi
authors.forename: Carmine
authors.initials: C
authors.lastname: Zoccali
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002116:Calcitonin / Q000627:therapeutic use*; D015740:Calcitonin Gene-Related Peptide; D018592:Cross-Over Studies; D000075222:Essential Hypertension; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007249:Inflammation / Q000188:drug therapy*; D011498:Protein Precursors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018401:Sample Size; D017673:Sodium Chloride, Dietary
chemical_list: D015415:Biomarkers; C000606589:CALCA protein, human; D011498:Protein Precursors; D017673:Sodium Chloride, Dietary; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide